iLoF
iLoF provides non-invasive biomarker detection and profiling using photonics combined with machine learning to accelerate drug discovery and patient stratification. The company captures optical fingerprints of gold-standard biomarkers and stores them in a cloud-based library that supports AI-driven analysis. Its platform targets clinical trial screening and candidate selection to reduce time and cost for pharmaceutical companies and clinical research organizations. iLoF focuses on applications including Alzheimer’s disease while expanding its capabilities to other therapeutic areas.
iLoF
iLoF provides non-invasive biomarker detection and profiling using photonics combined with machine learning to accelerate drug discovery and patient stratification. The company captures optical fingerprints of gold-standard biomarkers and stores them in a cloud-based library that supports AI-driven analysis. Its platform targets clinical trial screening and candidate selection to reduce time and cost for pharmaceutical companies and clinical research organizations. iLoF focuses on applications including Alzheimer’s disease while expanding its capabilities to other therapeutic areas.
